Ligand Pharmaceuticals, Inc. (LGND)
207.64
+4.72
(+2.33%)
USD |
NASDAQ |
Mar 16, 16:00
207.64
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Liabilities (Quarterly) : 543.42M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 675.63M |
| ADMA Biologics, Inc. | 156.03M |
| Merck & Co., Inc. | 84.20B |
| Globus Medical, Inc. | 729.51M |
| Establishment Labs Holdings, Inc. | 333.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.561B |
| Shareholders Equity (Quarterly) | 1.017B |
| Debt to Equity Ratio | 0.4439 |
| Current Ratio | 22.23 |
| Net Debt Paydown Yield | -2.38% |